Earlier studies have indicated that OCTN2 expression is dependent on the activation by PPAR-α and further confirmed by the observation that PPAR-α null mice develop carnitine deficiency from low OCTN2 expression [12,20]. Here, SLC22A5 is linked to systemic primary carnitine deficiency disease.